KEGG   ORTHOLOGY: K04726
Entry
K04726                      KO                                     

Name
BID
Definition
BH3 interacting domain death agonist
Pathway
ko01524  Platinum drug resistance
ko04071  Sphingolipid signaling pathway
ko04115  p53 signaling pathway
ko04210  Apoptosis
ko04215  Apoptosis - multiple species
ko04217  Necroptosis
ko04650  Natural killer cell mediated cytotoxicity
ko04932  Non-alcoholic fatty liver disease
ko05010  Alzheimer disease
ko05014  Amyotrophic lateral sclerosis
ko05022  Pathways of neurodegeneration - multiple diseases
ko05152  Tuberculosis
ko05160  Hepatitis C
ko05161  Hepatitis B
ko05162  Measles
ko05163  Human cytomegalovirus infection
ko05164  Influenza A
ko05167  Kaposi sarcoma-associated herpesvirus infection
ko05168  Herpes simplex virus 1 infection
ko05169  Epstein-Barr virus infection
ko05170  Human immunodeficiency virus 1 infection
ko05200  Pathways in cancer
ko05416  Viral myocarditis
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    K04726  BID; BH3 interacting domain death agonist
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    K04726  BID; BH3 interacting domain death agonist
   04215 Apoptosis - multiple species
    K04726  BID; BH3 interacting domain death agonist
   04217 Necroptosis
    K04726  BID; BH3 interacting domain death agonist
   04115 p53 signaling pathway
    K04726  BID; BH3 interacting domain death agonist
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    K04726  BID; BH3 interacting domain death agonist
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04726  BID; BH3 interacting domain death agonist
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04726  BID; BH3 interacting domain death agonist
   05014 Amyotrophic lateral sclerosis
    K04726  BID; BH3 interacting domain death agonist
   05022 Pathways of neurodegeneration - multiple diseases
    K04726  BID; BH3 interacting domain death agonist
  09166 Cardiovascular disease
   05416 Viral myocarditis
    K04726  BID; BH3 interacting domain death agonist
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    K04726  BID; BH3 interacting domain death agonist
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    K04726  BID; BH3 interacting domain death agonist
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    K04726  BID; BH3 interacting domain death agonist
   05161 Hepatitis B
    K04726  BID; BH3 interacting domain death agonist
   05160 Hepatitis C
    K04726  BID; BH3 interacting domain death agonist
   05164 Influenza A
    K04726  BID; BH3 interacting domain death agonist
   05162 Measles
    K04726  BID; BH3 interacting domain death agonist
   05168 Herpes simplex virus 1 infection
    K04726  BID; BH3 interacting domain death agonist
   05163 Human cytomegalovirus infection
    K04726  BID; BH3 interacting domain death agonist
   05167 Kaposi sarcoma-associated herpesvirus infection
    K04726  BID; BH3 interacting domain death agonist
   05169 Epstein-Barr virus infection
    K04726  BID; BH3 interacting domain death agonist
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    K04726  BID; BH3 interacting domain death agonist
Genes
HSA: 637(BID)
PTR: 458635(BID)
PPS: 100989555(BID)
GGO: 101142032(BID)
PON: 100173269(BID)
NLE: 100580571(BID)
MCC: 100426724(BID)
MCF: 102143226(BID)
CSAB: 103222876(BID)
RRO: 104676299(BID)
RBB: 108541711(BID)
CJC: 100403496(BID)
SBQ: 101040331(BID)
MMU: 12122(Bid)
MPAH: 110316901(Bid)
RNO: 64625(Bid)
MUN: 110546065(Bid)
CGE: 100754606(Bid)
NGI: 103745898(Bid)
HGL: 101710493(Bid) 101722472
CCAN: 109678183(Bid)
OCU: 100355991(BID)
TUP: 102477797(BID)
CFA: 100683675(BID)
VVP: 112917438(BID)
AML: 100465439(BID)
UMR: 103675694(BID)
UAH: 113258065(BID)
ORO: 101371120(BID)
ELK: 111159768
FCA: 100502578(BID)
PTG: 102951809(BID)
PPAD: 109276279(BID)
AJU: 106968455(BID)
BTA: 510373(BID)
BOM: 102279560(BID)
BBUB: 102399521(BID)
CHX: 102176106(BID)
OAS: 101117837(BID)
SSC: 594852(BID)
CFR: 102522363(BID)
CDK: 105100737(BID)
BACU: 103013636(BID)
LVE: 103078531(BID)
OOR: 101277745(BID)
DLE: 111176587(BID)
ECB: 100054988(BID)
EPZ: 103559205(BID)
EAI: 106839441(BID)
MYB: 102238957(BID)
MYD: 102751916(BID)
MNA: 107537702(BID)
HAI: 109373303(BID)
DRO: 112310499(BID)
PALE: 102887379(BID)
RAY: 107500447(BID)
MJV: 108385599(BID)
LAV: 100662196(BID)
TMU: 101356396
MDO: 100021895(BID)
SHR: 100929676(BID)
PCW: 110218747(BID)
OAA: 100088569(BID)
GGA: 395236(BID)
MGP: 100548073(BID)
CJO: 107315130(BID)
NMEL: 110395651(BID)
APLA: 101805365(BID)
ACYG: 106030927(BID)
TGU: 100228765(BID)
LSR: 110482645(BID)
SCAN: 103820468(BID)
GFR: 102036429(BID)
FAB: 101821709(BID)
PHI: 102110606(BID)
PMAJ: 107204331(BID)
CCAE: 111928077(BID)
CCW: 104692249(BID)
ETL: 114069005(BID)
FPG: 101917399(BID)
FCH: 102053879(BID)
CLV: 102093655(BID)
EGZ: 104134395(BID)
NNI: 104020245(BID)
ACUN: 113489093(BID)
PADL: 103924359(BID)
AAM: 106488953(BID)
ASN: 102375926
AMJ: 102574347(BID)
PSS: 102444174(BID)
CMY: 102941900(BID)
CPIC: 101936235(BID)
ACS: 100563997(bid)
PVT: 110076704(BID)
PBI: 103064959(BID)
PMUR: 107292278(BID)
TSR: 106542422(BID)
PMUA: 114605957(BID)
GJA: 107115459(BID)
XLA: 108704383(bid.L) 724076(bid.S)
XTR: 100036674(bid)
NPR: 108791565
DRE: 559425(bida)
IPU: 108264602
PHYP: 113534274
EEE: 113573581
NCC: 104947516
ONL: 100699927
OLA: 101156492
XMA: 111605875
XCO: 114155511
NFU: 107389357
POV: 109639913
HCQ: 109530353(bid)
BPEC: 110169733
MALB: 109961799
SASA: 106561376
OTW: 112218769
SALP: 111962614
ELS: 105018117
LCM: 102360597(BID)
CMK: 103186130
 » show all
Reference
PMID:9721221
  Authors
Footz TK, Birren B, Minoshima S, Asakawa S, Shimizu N, Riazi MA, McDermid HE
  Title
The gene for death agonist BID maps to the region of human 22q11.2 duplicated in cat eye syndrome chromosomes and to mouse chromosome 6.
  Journal
Genomics 51:472-5 (1998)
DOI:10.1006/geno.1998.5392
  Sequence
[hsa:637]
LinkDB

KEGG   ORTHOLOGY: K16341
Entry
K16341                      KO                                     

Name
BCL2L11, BIM
Definition
Bcl-2-like protein 11
Pathway
ko01521  EGFR tyrosine kinase inhibitor resistance
ko04068  FoxO signaling pathway
ko04151  PI3K-Akt signaling pathway
ko04210  Apoptosis
ko04215  Apoptosis - multiple species
ko04932  Non-alcoholic fatty liver disease
ko05169  Epstein-Barr virus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05210  Colorectal cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04068 FoxO signaling pathway
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
   04151 PI3K-Akt signaling pathway
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
   04215 Apoptosis - multiple species
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
   05206 MicroRNAs in cancer
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
  09162 Cancer: specific types
   05210 Colorectal cancer
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
  09172 Infectious disease: viral
   05169 Epstein-Barr virus infection
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    K16341  BCL2L11, BIM; Bcl-2-like protein 11
Genes
HSA: 10018(BCL2L11)
PTR: 459487(BCL2L11)
PPS: 100973549(BCL2L11)
GGO: 101149097(BCL2L11)
PON: 100443209(BCL2L11)
NLE: 100594069(BCL2L11)
MCC: 697082(BCL2L11)
MCF: 102135074(BCL2L11)
CSAB: 103241244(BCL2L11)
RRO: 104680402(BCL2L11)
RBB: 108518065(BCL2L11)
CJC: 100399968(BCL2L11)
SBQ: 101043528(BCL2L11)
MMU: 12125(Bcl2l11)
MCAL: 110289380(Bcl2l11)
MPAH: 110318278(Bcl2l11)
RNO: 64547(Bcl2l11)
MUN: 110559284(Bcl2l11)
CGE: 100771754(Bcl2l11)
NGI: 103750963(Bcl2l11)
HGL: 101721800(Bcl2l11)
CCAN: 109699272(Bcl2l11)
OCU: 100345483(BCL2L11)
TUP: 102500485(BCL2L11)
CFA: 612867(BCL2L11)
VVP: 112916634(BCL2L11)
AML: 100477763(BCL2L11)
UMR: 103671504(BCL2L11)
UAH: 113242278(BCL2L11)
ORO: 101378922(BCL2L11)
ELK: 111158508
FCA: 101084615(BCL2L11)
PTG: 102956471(BCL2L11)
PPAD: 109264822(BCL2L11)
AJU: 106976034(BCL2L11)
BTA: 507390(BCL2L11)
BOM: 102276156(BCL2L11)
BIU: 109565710(BCL2L11)
CHX: 102171716(BCL2L11)
OAS: 100505402(BCL2L11)
SSC: 396632(BCL2L11)
CFR: 102519481(BCL2L11)
CDK: 105092985(BCL2L11)
BACU: 103003003(BCL2L11)
LVE: 103071175(BCL2L11)
OOR: 101273293(BCL2L11)
DLE: 111187462(BCL2L11)
PCAD: 102976319(BCL2L11)
ECB: 100064312(BCL2L11)
EPZ: 103552644(BCL2L11)
EAI: 106838539(BCL2L11)
MYB: 102257135(BCL2L11)
MYD: 102755481(BCL2L11)
MNA: 107539638(BCL2L11)
HAI: 109393533(BCL2L11)
DRO: 112319403(BCL2L11)
PALE: 102890309(BCL2L11)
RAY: 107500664(BCL2L11)
MJV: 108394828(BCL2L11)
LAV: 100659585(BCL2L11)
TMU: 101352493
MDO: 100033215(BCL2L11)
SHR: 100932232(BCL2L11)
PCW: 110209301(BCL2L11)
OAA: 100073859(BCL2L11)
GGA: 107052854(BCL2L11)
CJO: 107310715(BCL2L11)
APLA: 113843059(BCL2L11)
TGU: 101233100(BCL2L11)
LSR: 110474316(BCL2L11)
SCAN: 103819332(BCL2L11)
FAB: 101819287(BCL2L11)
PHI: 102099885(BCL2L11)
PMAJ: 107201222(BCL2L11)
CCAE: 111926380(BCL2L11)
ETL: 114068850(BCL2L11)
FPG: 101918456(BCL2L11)
EGZ: 104128140(BCL2L11)
AAM: 106494355(BCL2L11)
ASN: 102381984(BCL2L11)
AMJ: 102560740(BCL2L11)
PSS: 102449034(BCL2L11)
CMY: 102932202(BCL2L11)
CPIC: 101936011(BCL2L11)
PVT: 110087021(BCL2L11)
PBI: 103063793(BCL2L11)
PMUR: 107291880(BCL2L11)
TSR: 106544506(BCL2L11)
PMUA: 114594798(BCL2L11)
GJA: 107114604(BCL2L11)
XLA: 108717788(bcl2l11.S) 734810(bcl2l11.L)
XTR: 613103(bcl2l11)
NPR: 108801166(BCL2L11)
DRE: 100190951(bcl2l11)
SANH: 107679163
IPU: 108263651(bcl2l11)
PHYP: 113541948(bcl2l11)
AMEX: 103047378(bcl2l11)
EEE: 113588707(bcl2l11)
TRU: 115249653(bcl2l11)
LCO: 104925571
MZE: 101474833
ONL: 102081903(bcl2l11)
OLA: 105355771
XMA: 106699886(bcl2l11)
XCO: 114138596(bcl2l11)
PRET: 103476441(bcl2l11)
CVG: 107089889(bcl2l11)
NFU: 107375876
KMR: 108242694(bcl2l11)
ALIM: 106515385(bcl2l11)
AOCE: 111571898
CSEM: 103386857(bcl2l11)
POV: 109645590(bcl2l11)
LCF: 108896263(bcl2l11)
SDU: 111227445(bcl2l11)
SLAL: 111661983(bcl2l11)
HCQ: 109512461(bcl2l11)
BPEC: 110157235
MALB: 109961081(bcl2l11)
SASA: 106577108(bcl2l11) 106608126
OTW: 112253141(bcl2l11) 112255614
ELS: 105010387(bcl2l11)
SFM: 108927156(bcl2l11)
PKI: 111852322(bcl2l11)
CMK: 103178941(bcl2l11)
 » show all
Reference
  Authors
Bouillet P, Strasser A
  Title
BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death.
  Journal
J Cell Sci 115:1567-74 (2002)
Reference
  Authors
U M, Miyashita T, Shikama Y, Tadokoro K, Yamada M
  Title
Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family.
  Journal
FEBS Lett 509:135-41 (2001)
DOI:10.1016/S0014-5793(01)03145-3
  Sequence
[hsa:10018]
LinkDB

KEGG   ORTHOLOGY: K10131
Entry
K10131                      KO                                     

Name
PMAIP1, NOXA
Definition
phorbol-12-myristate-13-acetate-induced protein 1
Pathway
ko01524  Platinum drug resistance
ko04115  p53 signaling pathway
ko04210  Apoptosis
ko04215  Apoptosis - multiple species
ko05200  Pathways in cancer
ko05203  Viral carcinogenesis
ko05210  Colorectal cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
   04215 Apoptosis - multiple species
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
   04115 p53 signaling pathway
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
   05203 Viral carcinogenesis
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
  09162 Cancer: specific types
   05210 Colorectal cancer
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    K10131  PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
Genes
HSA: 5366(PMAIP1)
PTR: 737247(PMAIP1)
PPS: 100979315(PMAIP1)
GGO: 101152154(PMAIP1)
PON: 100457415(PMAIP1)
NLE: 100593765(PMAIP1)
MCC: 702789(PMAIP1)
MCF: 102120192(PMAIP1)
RRO: 104673006(PMAIP1)
RBB: 108526400(PMAIP1)
CJC: 100404690(PMAIP1)
SBQ: 101044364(PMAIP1)
MMU: 58801(Pmaip1)
MCAL: 110285029(Pmaip1)
MPAH: 110333558(Pmaip1)
RNO: 492821(Pmaip1)
MUN: 110555473(Pmaip1)
CGE: 100755393(Pmaip1)
NGI: 103739615(Pmaip1)
HGL: 106010564(Pmaip1)
CCAN: 109701119(Pmaip1)
OCU: 103349392(PMAIP1)
TUP: 102497162(PMAIP1)
CFA: 100502558(PMAIP1)
VVP: 112919301(PMAIP1)
AML: 100474991(PMAIP1)
UAH: 113253468(PMAIP1)
ORO: 101362130(PMAIP1)
ELK: 111154272
FCA: 102900397(PMAIP1)
PTG: 102958923(PMAIP1)
PPAD: 109275651(PMAIP1)
AJU: 106978896(PMAIP1)
BTA: 100296226(PMAIP1)
BOM: 102285398(PMAIP1)
BIU: 109577992(PMAIP1)
BBUB: 102396135(PMAIP1)
CHX: 102175063(PMAIP1) 108633288
OAS: 101102359(PMAIP1)
SSC: 397278(PMAIP1)
CFR: 106729352(PMAIP1)
CDK: 105089011(PMAIP1)
BACU: 103009672(PMAIP1)
OOR: 101269536(PMAIP1)
DLE: 111180211(PMAIP1)
PCAD: 102980477(PMAIP1)
ECB: 100629496(PMAIP1)
EPZ: 103563750(PMAIP1)
EAI: 106842499(PMAIP1)
MYB: 102246714(PMAIP1)
MYD: 102767454(PMAIP1)
MNA: 107545406(PMAIP1)
HAI: 109381726(PMAIP1)
PALE: 102894490(PMAIP1)
RAY: 107516202(PMAIP1)
MJV: 108390232(PMAIP1)
LAV: 100677531(PMAIP1)
TMU: 101345213
OAA: 114810052(PMAIP1)
GGA: 770077(PMAIP1)
MGP: 104914820(PMAIP1)
CJO: 107305837(PMAIP1)
NMEL: 110390170(PMAIP1)
ACYG: 106036301(PMAIP1)
TGU: 105760854(PMAIP1)
LSR: 110484205(PMAIP1)
SCAN: 103822915(PMAIP1)
GFR: 102043659(PMAIP1)
FAB: 107604289(PMAIP1)
PHI: 102110157(PMAIP1)
PMAJ: 107216430(PMAIP1)
CCW: 104686752(PMAIP1)
ETL: 114070069(PMAIP1)
FPG: 106112088(PMAIP1)
CLV: 102097231(PMAIP1)
EGZ: 104133908(PMAIP1)
ACUN: 113489803(PMAIP1)
PADL: 103912216(PMAIP1)
AAM: 106499501(PMAIP1)
ASN: 112549505(PMAIP1)
PSS: 102454201(PMAIP1)
CMY: 102936530(PMAIP1)
CPIC: 101953262(PMAIP1)
ACS: 103280258(pmaip1)
PBI: 103049002(PMAIP1)
PMUR: 107290866(PMAIP1)
PMUA: 114606656(PMAIP1)
GJA: 107105807(PMAIP1)
NPR: 108798740(PMAIP1)
DRE: 751765(pmaip1)
 » show all
Reference
PMID:2398525
  Authors
Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K
  Title
Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line.
  Journal
J Virol 64:4632-9 (1990)
DOI:10.1128/JVI.64.10.4632-4639.1990
  Sequence
[hsa:5366]
Reference
  Authors
Ploner C, Kofler R, Villunger A
  Title
Noxa: at the tip of the balance between life and death.
  Journal
Oncogene 27 Suppl 1:S84-92 (2008)
DOI:10.1038/onc.2009.46
Reference
  Authors
Sun Y, Leaman DW
  Title
Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection.
  Journal
J Biol Chem 280:15561-8 (2005)
DOI:10.1074/jbc.M412630200
  Sequence
[hsa:5366]
LinkDB

KEGG   ORTHOLOGY: K10132
Entry
K10132                      KO                                     

Name
BBC3, PUMA
Definition
Bcl-2-binding component 3
Pathway
ko01524  Platinum drug resistance
ko04115  p53 signaling pathway
ko04210  Apoptosis
ko04215  Apoptosis - multiple species
ko04390  Hippo signaling pathway
ko05016  Huntington disease
ko05162  Measles
ko05200  Pathways in cancer
ko05210  Colorectal cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04390 Hippo signaling pathway
    K10132  BBC3, PUMA; Bcl-2-binding component 3
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    K10132  BBC3, PUMA; Bcl-2-binding component 3
   04215 Apoptosis - multiple species
    K10132  BBC3, PUMA; Bcl-2-binding component 3
   04115 p53 signaling pathway
    K10132  BBC3, PUMA; Bcl-2-binding component 3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K10132  BBC3, PUMA; Bcl-2-binding component 3
  09162 Cancer: specific types
   05210 Colorectal cancer
    K10132  BBC3, PUMA; Bcl-2-binding component 3
  09164 Neurodegenerative disease
   05016 Huntington disease
    K10132  BBC3, PUMA; Bcl-2-binding component 3
  09172 Infectious disease: viral
   05162 Measles
    K10132  BBC3, PUMA; Bcl-2-binding component 3
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    K10132  BBC3, PUMA; Bcl-2-binding component 3
Genes
HSA: 27113(BBC3)
PTR: 107969772(BBC3)
PPS: 100974112(BBC3)
GGO: 101125453(BBC3)
PON: 100452429(BBC3)
NLE: 100588342(BBC3)
MCC: 717955(BBC3)
MCF: 102119825(BBC3)
CSAB: 103234932(BBC3)
RRO: 104673391(BBC3)
RBB: 108523458
CJC: 100387604(BBC3)
MMU: 170770(Bbc3)
MCAL: 110297909(Bbc3)
MPAH: 110336584(Bbc3)
RNO: 317673(Bbc3)
MUN: 110561311(Bbc3)
CGE: 103164214(Bbc3)
NGI: 103724866(Bbc3)
HGL: 101714844(Bbc3)
CCAN: 109697533(Bbc3)
OCU: 100357703(BBC3)
TUP: 102499950(BBC3)
CFA: 612153(BBC3)
VVP: 112931366(BBC3)
AML: 100474559
UMR: 103657211(BBC3)
UAH: 113243380(BBC3)
ORO: 101366869(BBC3)
ELK: 111160670
FCA: 111558033(BBC3)
PTG: 102955464(BBC3)
PPAD: 109252887(BBC3)
AJU: 106973568(BBC3)
BTA: 782359(BBC3)
BOM: 102284902(BBC3)
BIU: 109571765(BBC3)
BBUB: 102415717(BBC3)
CHX: 102171367(BBC3)
OAS: 101123490(BBC3)
SSC: 100517403(BBC3)
CFR: 102512800(BBC3)
CDK: 105104049(BBC3)
BACU: 103003912(BBC3)
LVE: 103087294(BBC3)
OOR: 101275681(BBC3)
DLE: 111180693(BBC3)
PCAD: 102976277(BBC3)
ECB: 100146714(BBC3)
EPZ: 103560717(BBC3)
EAI: 106845162(BBC3)
MYB: 102253129(BBC3)
MYD: 102753249(BBC3)
MNA: 107540044(BBC3)
HAI: 109372194(BBC3) 109377257(MRPL55)
DRO: 112312833(BBC3)
PALE: 102892591(BBC3)
RAY: 107516010(BBC3)
MJV: 108398862(BBC3)
LAV: 100671262(BBC3)
TMU: 101348022
MDO: 100020711(BBC3)
SHR: 116423037(BBC3)
PCW: 110202397(BBC3)
PMAJ: 107198668(GNGT2)
CPIC: 101950846(BBC3)
 » show all
Reference
  Authors
Nakano K, Vousden KH
  Title
PUMA, a novel proapoptotic gene, is induced by p53.
  Journal
Mol Cell 7:683-94 (2001)
DOI:10.1016/s1097-2765(01)00214-3
  Sequence
[hsa:27113]
Reference
  Authors
Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH
  Title
BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program.
  Journal
Science 330:1390-3 (2010)
DOI:10.1126/science.1190217
  Sequence
[mmu:170770]
LinkDB

DBGET integrated database retrieval system